GlaxoSmithKline plc (GSK) Given "Neutral" Rating at Credit Suisse Group


's stock had its "neutral" rating restated by stock analysts at Credit Suisse Group in a report issued on Thursday. They presently have a GBX 1,750 price target on the stock.



from Biotech News